Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study

Area of Science:

• Neurology
• Neurodegenerative Diseases

Background:

• Multiple system atrophy (MSA) is a neurodegenerative disorder with parkinsonism, cerebellar syndrome, and dysautonomia.
• Recent Movement Disorder Society (MDS) criteria permit MSA diagnosis based on motor symptoms alone, excluding the need for autonomic dysfunction.

Purpose of the Study:

• To investigate the frequency and disease trajectory of MSA patients lacking dysautonomia.
• To compare the clinical course of MSA patients without dysautonomia to those with autonomic involvement.

Main Methods:

• Analysis of a multicenter cohort of autopsy-confirmed MSA patients.
• Categorization using MDS-MSA criteria and tracking of symptom evolution.
• Matching of motor-symptom-only patients with those exhibiting dysautonomia for comparison.

Main Results:

• 58% of 140 MSA patients initially presented without dysautonomia.
• Patients without dysautonomia had a significantly longer disease duration (8.1 years) compared to those with dysautonomia (6.3 years).
• Cerebellar onset MSA progressed faster to multisystem involvement than parkinsonian onset MSA.

Conclusions:

• The MDS-MSA criteria identify a motor-only subgroup with a distinct, potentially slower disease course.
• Including motor-only MSA patients in research is vital for understanding natural history and developing interventions.
• Retrospective data collection and symptom documentation variability are study limitations.